Ventodep ER 150 mg Cranialz
| Features | |
| Active substance | Venlafaxine |
| Also known as | Effexor XR |
| Blood pressure | Can increase blood pressure, monitoring recommended in cases of high doses or pre-existing hypertension |
| Chemical name | 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol |
| Dosage (medical) | Typically starts at 37.5 mg per day, can be increased up to 225 mg per day depending on the condition and patient response |
| Dosage (sports) | Not applicable |
| Effects | Antidepressant, anti-anxiety, mood stabilizer |
| Formula | C17H27NO2 |
| Half-life | Approximately 5 hours (venlafaxine), 11 hours (active metabolite desvenlafaxine) |
| Hepatotoxicity | Low risk, but caution advised in patients with pre-existing liver conditions |
| Lab Test | Not specifically monitored with lab tests, though liver enzymes may be checked periodically |
| Main action | Increases neurotransmitters serotonin and norepinephrine in the brain |
| Side effects | Nausea, dizziness, dry mouth, insomnia, loss of appetite, increased sweating, sexual dysfunction |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Strength | 150mg |
| Substance class | Serotonin-norepinephrine reuptake inhibitor (SNRI) |
| Trade name | Effexor, Effexor XR |
| Use in sports | None, not typically used in sports |
| Water Retention | Minimal |
| Manufacturer | Cranialz |
| Packing | 10 tabs/blister |